Skip to content

Mindful Eating and Current Glycemic Control in Patients With Type 2 Diabetes

The Association of Mindful Eating With Current Glycemic Control in Patients With Type 2 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06229847
Enrollment
448
Registered
2024-01-29
Start date
2019-07-01
Completion date
2019-12-30
Last updated
2024-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

type 2 diabetes, mindful eating, glycemic control, BMI

Brief summary

The goal of this observational study is to learn about the association of the level of mindful eating with the current glycemic control in patients with type 2 diabetes. The researchers will compare different glycemic control levels with the participants mindfulness while eating. And secondly, the researchers will compare the levels of eating awareness of those with and without obesity.

Detailed description

In type 2 diabetes, life style adaptations, mainly healthy eating, weight loss or control and exercise constitutes the foundation of type 2 diabetes management. In addition to regulating blood sugar levels, lifestyle modifications play a significant role in controlling risk factors such as hypertension and hyperlipidemia, delaying/preventing complications from developing, and even promoting diabetes regression. It is essential not only to focus on healthy food choices in dietary therapy but also to ensure patients achieve weight loss. Another crucial point is maintaining the continuity of these lifestyle changes. It is reported that it is quite challenging for patients to make lifestyle changes, adapt to the offered treatments, and furthermore, sustain this as a way of life. Adherence to these dietary changes is crucial for long-term success in managing diabetes and achieving weight loss goals. In a cross-sectional study conducted by Fanning and colleagues with 148 type 2 diabetic patients, it was found that conscious eating is associated with better diet adherence. In a review by Dunn et al., the available data strongly support the necessity of conscious eating as part of weight management programs. An American Heart Association statement highlights strong evidence that irregular eating patterns can make it difficult to maintain a healthy cardiometabolic profile, and emphasizes that conscious attention to mealtime and frequency can contribute to a healthier lifestyle and better management of cardiometabolic risk factors. In this study, the aim was to investigate the degree of eating mindfulness of patients with type 2 diabetes, and compare it between patients who had good glycemic control and patients with poorly controlled glycemic.

Interventions

None listed

Sponsors

Goztepe Prof Dr Suleyman Yalcın City Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* given consent to the study * having applied to Diabetes Outpatient Clinic for diabetes management * having diagnosed with type 2 diabetes for at least 6 months * having the mental competence to answer the questions in the questionnaire

Exclusion criteria

* Inconclusive diagnosis of type 2 diabetes * having not received or not using any treatment for diabetes

Design outcomes

Primary

MeasureTime frameDescription
mindful eating, its subgroups and diabetes control in patients with type 2 diabetesbaselineTo investigate the relationship between mindful eating and its subgroups with glycemic control, as evaluated by HbA1c, in individuals diagnosed with type 2 diabetes for at least 6 months.

Secondary

MeasureTime frameDescription
mindful eating, its subgroups and the presence of obesity in patients with type 2 diabetesbaselineTo investigate the relationship between mindful eating and its subgroups with obesity, as evaluated by body mass index, in individuals diagnosed with type 2 diabetes for at least 6 months.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026